133 related articles for article (PubMed ID: 7158508)
1. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
McBride WH; Moore K
Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
[No Abstract] [Full Text] [Related]
2. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
3. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
McBride WH; Woodruff MF; Forbes GM; Moore K
Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
[No Abstract] [Full Text] [Related]
4. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
[No Abstract] [Full Text] [Related]
5. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
Gupta N; Sehgal S; Aikat BK
Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
[No Abstract] [Full Text] [Related]
6. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
Moroson H; Stowe S; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
[No Abstract] [Full Text] [Related]
7. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
James K; Willmott N; Milne I; McBride WH
J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
[TBL] [Abstract][Full Text] [Related]
8. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
Keller R
J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
[TBL] [Abstract][Full Text] [Related]
10. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
Woodruff MF; McBride WH; Dunbar N
Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
[TBL] [Abstract][Full Text] [Related]
11. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
12. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
Bomford R
Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
Mendiondo O; Suit H; Fixler H
Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
[No Abstract] [Full Text] [Related]
14. Rate of tumour inhibition by activated macrophages in vitro.
Orinda DA
East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
[No Abstract] [Full Text] [Related]
15. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
Ghaffar A; Cullen RT; Woodruff MA
Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and immunotherapy of diabetic and non-diabetic mice bearing fibrosarcoma.
Pavelić K; Hrsak I
Eur J Cancer (1965); 1980 Oct; 16(10):1297-301. PubMed ID: 7009161
[No Abstract] [Full Text] [Related]
17. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
Conley FK
J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
[No Abstract] [Full Text] [Related]
18. Antitumor activity of purified cell walls from Corynebacterium parvum.
Riveros-Moreno V; Bomford R; Scott MT
J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
[TBL] [Abstract][Full Text] [Related]
19. Simple estimation of macrophage activity in tumour-bearing animals treated with Corynebacterium parvum.
Wilson RG
Br J Exp Pathol; 1981 Aug; 62(4):347-9. PubMed ID: 7295527
[TBL] [Abstract][Full Text] [Related]
20. Immune reaction of tumor-bearing mice to Propionibacterium acnes and the antitumor effect of the bacteria.
Silobrcic V; Fredrickson G; Sedlacek R; Suit HD; Wolberg G
Cancer Immunol Immunother; 1982; 14(1):10-2. PubMed ID: 6925459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
